Newsmeme!
Discover News you didn't know existed
Shareholder-friendly stocks that have been marked to underperform the market.
THURSDAY, Dec. 4 (HealthDay News) -- During pregnancy, many of the mother's cells enter the fetus and produce immune cells that prevent the growing baby from rejecting its mother, new research shows.
To help develop an effective HIV vaccine, researchers are trying to better understand how the immune systems of a small minority of HIV-infected people known as long-term non-progressors (LTNPs) contain the virus naturally. CD8+ T cells, which kill cells infected with HIV, enable LTNPs to control HIV, but it has been unclear how CD8+ T cells mediate that control so effectively. A new report ...
( NIH/National Institute of Allergy and Infectious Diseases ) Researchers are trying to better understand how the immune systems of a minority of HIV-infected people known as long-term nonprogressors (LTNPs) contain the virus naturally. CD8+ T cells, which kill cells infected with HIV, enable LTNPs to control HIV, but it has been unclear how CD8+ T cells mediate that control so effectively. A ...
SAN DIEGO----Headline of release should read: Inovio Biomedical and VGX Pharmaceuticals to Highlight Recent Advances in Electroporation-Delivered DNA Vaccines at International DNA Vaccines Conference
Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in "teaching" the immune system how to fight off repeated infections of the same virus. The findings, available online and in the Dec. 15 issue of the Journal of Immunology, have potential application in the development of more effective vaccines and anti-viral therapies.
Novelos Therapeutics, Inc. (OTCBB: NVLT) , a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced that today Novelos is presenting two scientific posters, based on collaborations with Dr. Marcela Diaz-Montero of the University of Miami Sylvester Cancer Center and with Dr. Mark Poznansky of the Massachusetts General Hospital, affiliated ...
NEWTON, Mass.----Novelos Therapeutics, Inc. , a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced that today Novelos is presenting two scientific posters, based on collaborations with Dr.
Coeliac UK, the national charity for people with coeliac disease, is hosting a conference on Wednesday 3rd December at the Royal Society of Arts in central London announcing the latest findings in coeliac disease research including progress on the development of a possible vaccine for the condition.
Inovio Biomedical Corporation (NYSE Alternext: INO) and VGX Pharmaceuticals announced today they will make multiple presentations concerning electroporation-delivered DNA vaccines in the fight against cancer, HIV and other infectious diseases at DNA Vaccines 2008 , a conference hosted by The International Society of DNA Vaccines in Las Vegas, NV, at The Tropicana Hotel, December 9-11. ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |